Kwon Soon-Kyeong, Kim Seong Keun, Lee Dae-Hee, Kim Jihyun F
Department of Systems Biology and Division of Life Sciences, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Republic of Korea.
Biosystems and Bioengineering Program, University of Science and Technology (UST), 217 Gajung-ro, Yuseong-gu, Daejeon 305-350, Republic of Korea.
Sci Rep. 2015 Nov 4;5:16076. doi: 10.1038/srep16076.
Achieving sufficient yields of proteins in their functional form represents the first bottleneck in contemporary bioscience and biotechnology. To accomplish successful overexpression of membrane proteins in a workhorse organism such as E. coli, defined and rational optimization strategies based on an understanding of the genetic background of the toxicity-escape mechanism are desirable. To this end, we sequenced the genomes of E. coli C41(DE3) and its derivative C43(DE3), which were developed for membrane protein production. Comparative analysis of their genomes with those of their ancestral strain E. coli BL21(DE3) revealed various genetic changes in both strains. A series of E. coli variants that are able to tolerate transformation with or overexpression of membrane proteins were generated by in vitro evolution. Targeted sequencing of the evolved strains revealed the mutational hotspots among the acquired genetic changes. By these combinatorial approaches, we found non-synonymous changes in the lac repressor gene of the lac operon as well as nucleotide substitutions in the lacUV5 promoter of the DE3 region, by which the toxic effect to the host caused by overexpression of membrane proteins could be relieved. A mutation in lacI was demonstrated to be crucial for conferring tolerance to membrane protein overexpression.
以功能形式获得足够产量的蛋白质是当代生物科学和生物技术中的第一个瓶颈。为了在诸如大肠杆菌这样的常用生物中成功实现膜蛋白的过表达,基于对毒性逃逸机制遗传背景的理解,制定明确且合理的优化策略是很有必要的。为此,我们对用于膜蛋白生产的大肠杆菌C41(DE3)及其衍生物C43(DE3)的基因组进行了测序。将它们的基因组与其祖先菌株大肠杆菌BL21(DE3)的基因组进行比较分析,发现这两个菌株都有各种基因变化。通过体外进化产生了一系列能够耐受膜蛋白转化或过表达的大肠杆菌变体。对进化菌株的靶向测序揭示了获得的基因变化中的突变热点。通过这些组合方法,我们发现了乳糖操纵子的乳糖阻遏物基因中的非同义变化以及DE3区域的lacUV5启动子中的核苷酸取代,通过这些变化可以减轻膜蛋白过表达对宿主造成的毒性作用。已证明lacI中的突变对于赋予对膜蛋白过表达的耐受性至关重要。